Anthraquinone-based compounds are attractive target for the design of new anticancer drugs. We have previously described a series of 1, 5-and 1, 4-difunctionalized anthraquinones, which exhibit different spectra of potency, together with human telomerase evaluation. The present study details the preparation of further, distinct series of regioisomeric difunctionalized amidoanthraquinone and examines their in vitro cytotoxicity ...